Javad Shahidi
Keine laufenden Positionen mehr
Vermögen: 1 Mio $ am 31.05.2024
Karriereverlauf von Javad Shahidi
Ehemalige bekannte Positionen von Javad Shahidi
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CENTESSA PHARMACEUTICALS PLC | Technik-/Wissenschafts-/F&E-Leiter | 07.03.2022 | 14.10.2022 |
Daiichi Sankyo, Inc.
 Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2019 | 01.03.2022 |
Ausbildung von Javad Shahidi
| McGill University | Graduate Degree |
| Shahid Beheshti University of Medical Sciences | Doctorate Degree |
Statistik
International
| Kanada | 2 |
| Vereinigte Staaten | 2 |
| Iran | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CENTESSA PHARMACEUTICALS PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Health Technology |
- Börse
- Insiders
- Javad Shahidi
- Erfahrung